BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakraborty P, Bajeli S, Kaushal D, Radotra BD, Kumar A. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. Nat Commun 2021;12:1606. [PMID: 33707445 DOI: 10.1038/s41467-021-21748-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Guéneau V, Plateau-gonthier J, Arnaud L, Piard J, Castex M, Briandet R. Positive biofilms to guide surface microbial ecology in livestock buildings. Biofilm 2022;4:100075. [DOI: 10.1016/j.bioflm.2022.100075] [Reference Citation Analysis]
2 Sharma A, Vashistt J, Shrivastava R. Mycobacterium fortuitum fabG4 knockdown studies: Implication as pellicle and biofilm specific drug target. J Basic Microbiol 2022. [PMID: 35736669 DOI: 10.1002/jobm.202200230] [Reference Citation Analysis]
3 Smith TM, Youngblom MA, Kernien JF, Mohamed MA, Fry SS, Bohr LL, Mortimer TD, O'Neill MB, Pepperell CS. Rapid adaptation of a complex trait during experimental evolution of Mycobacterium tuberculosis. Elife 2022;11:e78454. [PMID: 35726854 DOI: 10.7554/eLife.78454] [Reference Citation Analysis]
4 Ning H, Liang X, Xie Y, Bai L, Zhang W, Wang L, Kang J, Lu Y, Ma Y, Bai G, Bai Y. c-di-AMP Accumulation Regulates Growth, Metabolism, and Immunogenicity of Mycobacterium smegmatis. Front Microbiol 2022;13:865045. [DOI: 10.3389/fmicb.2022.865045] [Reference Citation Analysis]
5 Gupta S, Mishra DK, Khan MZ, Saini V, Mehta D, Kumar S, Yadav A, Mitra M, Rani P, Singh M, Nandi CK, Das P, Ahuja V, Nandicoori VK, Bajaj A. Development of a Highly Specific, Selective, and Sensitive Fluorescent Probe for Detection of Mycobacteria in Human Tissues. Adv Healthc Mater 2022;11:e2102640. [PMID: 35038229 DOI: 10.1002/adhm.202102640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Daniel C, Bhakta S. Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections. Immunobiology 2022;227:152224. [DOI: 10.1016/j.imbio.2022.152224] [Reference Citation Analysis]
7 Dartois VA, Rubin EJ. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol 2022. [PMID: 35478222 DOI: 10.1038/s41579-022-00731-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hu J, Chen S, Yang Y, Li L, Cheng X, Cheng Y, Huang Q. A Smart Hydrogel with Anti-Biofilm and Anti-Virulence Activities to Treat Pseudomonas aeruginosa Infections. Adv Healthc Mater 2022;:e2200299. [PMID: 35306745 DOI: 10.1002/adhm.202200299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pontes JTCD, Toledo Borges AB, Roque-borda CA, Pavan FR. Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria. Pharmaceutics 2022;14:642. [DOI: 10.3390/pharmaceutics14030642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Viljoen A, Dufrêne YF, Nigou J. Mycobacterial Adhesion: From Hydrophobic to Receptor-Ligand Interactions. Microorganisms 2022;10:454. [DOI: 10.3390/microorganisms10020454] [Reference Citation Analysis]
11 Kumari Nilesh Vyas H, Xia B, Mai-prochnow A. Clinically relevant in vitro biofilm models: A need to mimic and recapitulate the host environment. Biofilm 2022. [DOI: 10.1016/j.bioflm.2022.100069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang X, Xie Z, Zhao J, Zhu Z, Yang C, Liu Y. Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections. Front Cell Infect Microbiol 2021;11:758392. [PMID: 34938668 DOI: 10.3389/fcimb.2021.758392] [Reference Citation Analysis]
13 Oluyori AP, Rode HB. Mycobacterium tuberculosis biofilm inhibitors. Future Med Chem 2021. [PMID: 34913388 DOI: 10.4155/fmc-2021-0281] [Reference Citation Analysis]
14 Bekier A, Kawka M, Lach J, Dziadek J, Paneth A, Gatkowska J, Dzitko K, Dziadek B. Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity. Cells 2021;10:3476. [PMID: 34943984 DOI: 10.3390/cells10123476] [Reference Citation Analysis]
15 Bacon J, Waddell SJ, Flores-Valdez MA. Biofilms in tuberculosis: What have we learnt in the past decade and what is still unexplored? Tuberculosis (Edinb) 2021;132:102153. [PMID: 34839080 DOI: 10.1016/j.tube.2021.102153] [Reference Citation Analysis]
16 Medina-Alarcón KP, Tobias da Silva IP, Ferin GG, Pereira-da-Silva MA, Marcos CM, Dos Santos MB, Regasini LO, Chorilli M, Mendes-Giannini MJS, Pavan FR, Fusco-Almeida AM. Mycobacterium tuberculosis and Paracoccidioides brasiliensis Formation and Treatment of Mixed Biofilm In Vitro. Front Cell Infect Microbiol 2021;11:681131. [PMID: 34790584 DOI: 10.3389/fcimb.2021.681131] [Reference Citation Analysis]
17 Oliveira WK, Ávila HL, Tadra MZ, Cardoso RL, Fadel-Pichet CMT, de Souza EM, de Oliveira Pedrosa F, Faoro H. High Genomic Identity between Clinical and Environmental Strains of Herbaspirillum frisingense Suggests Pre-Adaptation to Different Hosts and Intrinsic Resistance to Multiple Drugs. Antibiotics (Basel) 2021;10:1409. [PMID: 34827347 DOI: 10.3390/antibiotics10111409] [Reference Citation Analysis]
18 Belardinelli JM, Li W, Avanzi C, Angala SK, Lian E, Wiersma CJ, Palčeková Z, Martin KH, Angala B, de Moura VCN, Kerns C, Jones V, Gonzalez-Juarrero M, Davidson RM, Nick JA, Borlee BR, Jackson M. Unique Features of Mycobacterium abscessus Biofilms Formed in Synthetic Cystic Fibrosis Medium. Front Microbiol 2021;12:743126. [PMID: 34777289 DOI: 10.3389/fmicb.2021.743126] [Reference Citation Analysis]
19 Gupta KR, Arora G, Mattoo A, Sajid A. Stringent Response in Mycobacteria: From Biology to Therapeutic Potential. Pathogens 2021;10:1417. [PMID: 34832573 DOI: 10.3390/pathogens10111417] [Reference Citation Analysis]
20 Weathered C, Pennington K, Escalante P, Pienaar E. The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection. J Theor Biol 2021;:110949. [PMID: 34717938 DOI: 10.1016/j.jtbi.2021.110949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Abidi W, Torres-Sánchez L, Siroy A, Krasteva PV. Weaving of bacterial cellulose by the Bcs secretion systems. FEMS Microbiol Rev 2021:fuab051. [PMID: 34634120 DOI: 10.1093/femsre/fuab051] [Reference Citation Analysis]
22 Artzy-Schnirman A, Arber Raviv S, Doppelt Flikshtain O, Shklover J, Korin N, Gross A, Mizrahi B, Schroeder A, Sznitman J. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Adv Drug Deliv Rev 2021;176:113901. [PMID: 34331989 DOI: 10.1016/j.addr.2021.113901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
23 Zhou W, Yang B, Zou Y, Rahman K, Cao X, Lei Y, Lai R, Fu ZF, Chen X, Cao G. Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates. Front Microbiol 2021;12:658637. [PMID: 34276592 DOI: 10.3389/fmicb.2021.658637] [Reference Citation Analysis]
24 Savijoki K, Myllymäki H, Luukinen H, Paulamäki L, Vanha-Aho LM, Svorjova A, Miettinen I, Fallarero A, Ihalainen TO, Yli-Kauhaluoma J, Nyman TA, Parikka M. Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance, and Persistence. mSystems 2021;6:e0050021. [PMID: 34156290 DOI: 10.1128/mSystems.00500-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Meldrum OW, Chotirmall SH. Mucus, Microbiomes and Pulmonary Disease. Biomedicines 2021;9:675. [PMID: 34199312 DOI: 10.3390/biomedicines9060675] [Reference Citation Analysis]
26 Ding L, Wang J, Cai S, Smyth H, Cui Z. Pulmonary biofilm-based chronic infections and inhaled treatment strategies. Int J Pharm 2021;604:120768. [PMID: 34089796 DOI: 10.1016/j.ijpharm.2021.120768] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]